CHRIS MCCOY: Open Payments
NPI 1164675880 · LOGAN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 46 payments from 8 companies in 2025. Trend: 2023 $102 · 2024 $379 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $281 |
| Indivior Inc. | 11 | $189 |
| ABBVIE INC. | 11 | $160 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Braeburn Inc. | 2 | $31 |
| Gilead Sciences, Inc. | 1 | $24 |
| Smith+Nephew, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $8 |
Products named: CAPLYTA, SUBLOCADE, VRAYLAR, FANAPT, BRIXADI, COLLAGENASE SANTYL, UBRELVY, QULIPTA.
Industry payments across WV — which companies pay providers there.
